Today in @Nature we report a new prime editing strategy that can rescue a common cause of many genetic diseases in a disease-agnostic manner. This approach converts a redundant endogenous tRNA into an optimized suppressor tRNA, enabling a single prime edit to rescue premature stop codons across different diseases.
(1/15)
https://t.co/zs0qu5bhXx
Our Victorian Chapter, AAMRI VIC, was disappointed today to see the Vic Govt has reduced funding for medical research in the 24/25 Budget, despite Vic scientists leading the way in their research & contributions to the VIC economy. @BenCarrollMP https://t.co/wDOBjXJTNC👇
WEHI's Dr Sarah Diepstraten spoke with @10NewsFirstMelb about the novel combination of two cancer drugs that has shown great potential as a future treatment for patients with acute myeloid leukaemia (AML).
Watch the segment 👇
Punching high! 🥊 WEHI researchers discovered that a duo of existing cancer drugs – venetoclax and a STING agonist – can KO #AML. As famous boxer Muhammad Ali might say, this treatment ‘floats like a butterfly & STINGs like a bee’!
Read more 👉https://t.co/2nn2s3k0Do
🧵1/2
📢JOB Alert📢The Petermac Translational Research Centres are looking for Immunology Lead Scientist! Great opportunity to coordinate and conduct multiple translational research projects with a focus on immune biomarkers.🔬 Applications close 22 Aug 2023.
https://t.co/4Dz5WKIUMe
C0VID & excess deaths: The last 3 years have seen a very big increase in total deaths in the world.
As this analysis from The Economist shows, C0VID is responsible for basically all of it.
2022 worse than 2020
XS death rates still high in 2023
https://t.co/8JaptlHIZ9
The @JohnstoneLab are hiring! We are looking for a Bioinformatician/computational biologist to join our group. Transcription, chromatin biology and cancer immunology is our focus. Interested? Check out the position description @PeterMacRes@PeterMacCC
https://t.co/pZKEPCRbBn